FDA update on Breast Implant Associated-Squamous Cell Carcinoma

The FDA has produced an update on Breast Implant Associated Squamous Cell Carcinoma (BIA-SCC)

This is extremely rare (only 19 cases recorded) however occurring with smooth and textured implants and more aggressive than BIA-ALCL.

Importantly they are recommending that this should be mentioned in the consent process.

View the update here

Other News Articles

9th September
ABS statement on the role of the physician’s associate (PA) within the breast team

The ABS issued a statement on the role of PAs within the breast team on the 9th September 2024
30th August
Introduction to Breast Care Nursing Course: Mentors Required
30th August
GMC Assessment Pilots

Find out about taking part in breast surgery pilot exams